Live Quote · NASDAQFHTXHealthcare· Biotechnology

Foghorn Therapeutics Inc.

$5.30 5.79%(+$0.29)
TickerSpark Score
66/100
Solid
30
Valuation
50
Profitability
100
Growth
68
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FHTX research report →

52-Week Range55% of range
Low
$3.27
Current
$5.30
High
$6.95
Company Overviewfoghorntx.com

About the company

Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing medicines. Their focus is on addressing genetically determined vulnerabilities within the chromatin regulatory system.

CEO
Adrian H. Gottschalk
IPO
2020
Employees
112
HQ
Cambridge, MA, US

Price Chart

+7.07% · this period
$6.68$5.10$3.53Jul 02Dec 31Jul 02
Valuation
Market Cap
$311.18M
P/E
-4.53
P/S
11.03
P/B
-4.82
EV/EBITDA
-3.64
Div Yield
0.00%
Profitability
Gross Margin
22.26%
Op Margin
-286.16%
Net Margin
-266.88%
ROE
85.78%
ROIC
-50.60%
Growth & Income
Revenue
$30.91M · 36.75%
Net Income
$-74,283,000 · 14.24%
EPS
$-1.18 · 25.32%
Op Income
$-82,107,000
FCF YoY
14.97%
Performance & Tape
52W High
$6.95
52W Low
$3.27
50D MA
$4.32
200D MA
$4.82
Beta
2.89
Avg Volume
178.14K

Get TickerSpark's AI analysis on FHTX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 24, 26Lynch Thomas J. Jr.other28,000
Jun 24, 26Duty Stuartother28,000
Jun 24, 26Biller Scottother28,000
Jun 24, 26Gallagher Neilother28,000
Jun 24, 26Mendelsohn Michaelother28,000
Jun 24, 26SMITH IAN Fother28,000
Jun 24, 26GILL SIMBAother28,000
Jun 24, 26PARSHALL B LYNNEother28,000
Jun 24, 26Cole Douglas G.other28,000
Apr 10, 26GOTTSCHALK ADRIANother59,208
Coverage · FHTX

Our FHTX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on FHTX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate FHTX report →
Internal Compare

Similar companies

Peers in the same neighborhood.